Journal of Regenerative MedicineISSN: 2325-9620

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Stem Cell Therapy for Diabetes: A Call for Efficient Differentiation of Pancreatic Progenitors

Stem Cell Therapy for Diabetes: A Call for Efficient Differentiation of Pancreatic Progenitors

Given the capacity of differentiating into functional beta cells in vivo, transplantation of pancreatic progenitors derived from human embryonic stem cells (hESCs) has been considered as a promising avenue in beta cell replacement therapy . Besides the concerns of preventing teratoma formation, reducing host immune system rejection and other related safety issues , generating sufficient number of pancreatic progenitors is one of the priorities before any consideration of clinical application.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

GET THE APP